Rating History for Amylin Pharmaceuticals (AMLN) by Piper Jaffray

More Stocks Rated by Piper Jaffray | Latest Ratings for AMLN
Date Type Rating
(Past)		 PT
(Past)		 Start $ End $ % Chg. Details
3/28/2012 Downgrade Neutral
(N/A)		 21.00
(N/A)		 15.39 30.98 101.3% Details
1/27/2011 Upgrade Overweight
(N/A)		 N/A
(N/A)		 16.10 15.39 -4.41% Details